Utility of 18-fluorodeoxyglucose positron emission tomography in children with relapsed/refractory leukemia

References

• Valls L, Badve C, Avril S, et al. FDG-PET imaging in hematological malignancies. Blood Rev. 2016;30(4):317–331.
   PubMed Web of Science ®Google Scholar
• Padma S, Sundaram PS, Tewari A. PET/CT in paediatric malignancies – an update. Indian J Med Paediatr Oncol. 2016;37(3):131–140.
   PubMed Web of Science ®Google Scholar
• Adams HJ, Nievelstein RA, Kwee TC. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Rev. 2015;29(6):417–425.
   PubMed Web of Science ®Google Scholar
• Cunningham I, Kohno B. 18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases. Am J Hematol. 2016;91(4):379–384.
   PubMed Web of Science ®Google Scholar
• Koçak U, Gürsel T, Kaya Z, et al. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia-experience of a single center. Pediatr Hematol Oncol. 2012;29(2):130–140.
   PubMed Web of Science ®Google Scholar
• Gibson BE, Webb DK, Howman AJ, et al. Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. Br J Haematol. 2011;155(3):366–376.
   PubMed Web of Science ®Google Scholar
• Kaya Z, Alıcı N, Özmen ÖE, et al. Identification of renal infiltration based on urinary findings in a child with Burkitt leukemia/lymphoma. Am J Hematol. 2017;92(8):839–840.
   PubMed Web of Science ®Google Scholar
• Ohanian M, Faderl S, Ravandi F, et al. Is acute myeloid leukemia a liquid tumor? Int J Cancer. 2013;133(3):534–543.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Schrappe M, Bernardo ME, Rutella S. How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012;120(14):2807–2816.
   PubMed Web of Science ®Google Scholar
• Stölzel F, Röllig C, Radke J, et al. 18FFDG-PET/CT for detection of extramedullary acute myeloid leukemia. Haematologica 2011;96(10):1552–1556.
   PubMed Web of Science ®Google Scholar
• Zhou WL, Wu HB, Wang LJ, et al. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia. Eur J Radiol. 2016;85(1):205–210.
   PubMed Web of Science ®Google Scholar
• Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma. 2006;47(9):1754–1767.
   PubMed Web of Science ®Google Scholar
• Ge L, Ye F, Mao X, et al. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2014;20(7):1040–1047.
   PubMed Web of Science ®Google Scholar
• Chandra P, Dhake S, Purandare N, et al. Role of FDG PET/CT in diagnostic evaluation of granulocytic sarcomas: a series of 12 patients. Indian J Nucl Med. 2017;32(3):198–202.
   PubMed Web of Science ®Google Scholar
• Douglas A, Lau E, Thursky K, Slavin M. What, where and why: exploring fluorodeoxyglucose-PET’s ability to localize and differentiate infection from cancer. Curr Opin Infect Dis.2017;30(6):552–564.
   PubMed Web of Science ®Google Scholar
• Calvaruso M, Gulino A, Buffa S, et al. Challenges and new prospects in Hepatosplenic γδ T-cell lymphoma. Leuk Lymphoma. 2014;55(11):2457–2465.
   PubMed Web of Science ®Google Scholar
• Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000;14(6):991–997.
   PubMed Web of Science ®Google Scholar
• Barrington SF, Kluge R. FDG-PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017;44(S1):97–110.
   PubMedGoogle Scholar
• Ilivitzki A, Radan L, Ben-Arush M, et al. Early interim FDG-PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low dose CT. Pediatr Radiol. 2013;43(1):86–92.
   PubMed Web of Science ®Google Scholar
• Depas G, De Barsy C, Jerusalem G, et al. 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging. 2005;32(1):31–38.
   PubMed Web of Science ®Google Scholar
• Lesesve JF, Schneider P, Dolgopolov I, et al. Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing’s sarcoma. Med Pediatr Oncol. 1997;29(2):132–134.
   PubMedGoogle Scholar
• Schmiegelow K, Levinsen MF, Attarbaschi A, et al. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013;31(19):2469–2476.
   PubMed Web of Science ®Google Scholar
• Intzes S, Wiersma S, Meyerson HJ. Myelomastocytic leukemia with t(8;21) in a 3-year-old Child. J Pediatr Hematol Oncol. 2011;33(8):e372–e375.
   PubMed Web of Science ®Google Scholar
• Lynott A, Ravandi-Kashani F, Giles FJ. Malignancy: case report: hypereosinophilia progressing to granulocytic sarcoma and acute myelocytic leukemia with trisomy 8: a case report and review of the literature. Hematology 1999;4(6):487–493.
   PubMedGoogle Scholar
• Alam MS, Fu L, Ren YY, et al. 18F-FDG super bone marrow uptake: a highly potent indicator for the malignant infiltration. Medicine (Baltimore). 2016;95(52):e5579.
   PubMed Web of Science ®Google Scholar
• Adams HJ, Kwee TC, de Keizer B, et al. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol. 2014;25(5):921–927.
   PubMed Web of Science ®Google Scholar
• Adams HJ, Kwee TC, Fijnheer R, et al. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match. Ann Nucl Med. 2015;29(2):132–137.
   PubMed Web of Science ®Google Scholar
• Kaya Z, Kocak U, Albayrak M, et al. Granulocytic sarcoma after stem cell transplantation in a child with biphenotypic leukemia. Turk J Haematol. 2009;26(3):151–153.
   PubMed Web of Science ®Google Scholar
• Ishii A, Kondo T, Oka T, et al. Granulocytic sarcoma of the pancreas on 18F-FDG PET/CT: a case report. Medicine (Baltimore). 2016;95(49):e5570.
   PubMed Web of Science ®Google Scholar